Literature DB >> 32255235

Ameliorative effects of Magnolia sieboldii buds hexane extract on experimental reflux esophagitis.

Li Nan1, Hyeon Hwa Nam2, Byung Yong Park3, Beom Tae Kim4, Byung Kil Choo1.   

Abstract

Gastroesophageal reflux disease (GERD) is a disease that stomach contents continually refluxing into esophagus causes symptoms and/or complications. The study was working to find natural plant extracts with good effects and small side effects to treat reflux esophagitis (RE). The anti-inflammatory effects of hexane extract of Magnolia sieboldii (MsHE) were conducted on lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophage cells. The ameliorative effects of MsHE on esophageal damage in rats induced by gastric acid reflux was explored in vivo. The results showed that MsHE decreased the production of nitric oxide (NO) and expression levels of iNOS, COX-2 and TNF-α on LPS-stimulated RAW 264.7 cells and MsHE treatment ameliorated the rats' esophageal tissue damage induced by gastric acid and inhibited the increase of inflammatory mediators and pro-inflammatory cytokines by regulating NF-κB signaling pathway. In addition, MsHE protected the function of barrier of epithelial cells against inflammatory conditions through increasing the expression of tight junctions. Furthermore, liquid chromatography-mass spectrometry analysis was used for determine the active ingredients contained in MsHE. The results show that MsHE can alleviate experimental rat RE by regulating NF-κB signaling pathway. In summary, MsHE may be used as a source material of drug candidate for the treatment of RE.
© 2020 John Wiley & Sons, Ltd.

Entities:  

Keywords:  zzm321990Magonolia sieboldii; NF-κB signaling pathway; anti-inflammatory effects; cytokines; esophageal damage; reflux esophagitis

Year:  2020        PMID: 32255235     DOI: 10.1002/ptr.6689

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  2 in total

1.  Network Pharmacology Analysis of Hewei Jiangni Granule for Gastroesophageal Reflux Disease and Experimental Verification of Its Anti-Neurogenic Inflammation Mechanism.

Authors:  Yuan Cheng; Fushun Kou; Xiaosi Zhang; Yi Dai; Lei Shi; Chune Xie; Xiaohong Li; Junxiang Li
Journal:  Drug Des Devel Ther       Date:  2022-05-05       Impact factor: 4.319

Review 2.  NF-κB: A novel therapeutic pathway for gastroesophageal reflux disease?

Authors:  Mao-Lin Zhang; Long-Qing Ran; Meng-Jun Wu; Qin-Chen Jia; Zhi-Ming Qin; Yong G Peng
Journal:  World J Clin Cases       Date:  2022-08-26       Impact factor: 1.534

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.